A tumor sorting protocol that enables enrichment of pancreatic adenocarcinoma cells and facilitation of genetic analyses.
暂无分享,去创建一个
D. Eberhard | Stephanie Johnson | M. Lackner | Z. Boyd | R. Raja | Rajiv Raja | Mark R Lackner | David A Eberhard | Stephanie Johnson | Zachary S Boyd
[1] R. Hruban,et al. Genome-Wide Allelotypes of Familial Pancreatic Adenocarcinomas and Familial and Sporadic Intraductal Papillary Mucinous Neoplasms , 2007, Clinical Cancer Research.
[2] D. Klimstra,et al. K-ras mutations in pancreatic ductal proliferative lesions. , 1994, The American journal of pathology.
[3] Luc Girard,et al. An integrated view of copy number and allelic alterations in the cancer genome using single nucleotide polymorphism arrays. , 2004, Cancer research.
[4] C. Chelala,et al. Genome-wide DNA copy number analysis in pancreatic cancer using high-density single nucleotide polymorphism arrays , 2008, Oncogene.
[5] R. Hruban,et al. Genome-wide aberrations in pancreatic adenocarcinoma. , 2005, Cancer genetics and cytogenetics.
[6] R. Hruban,et al. BRAF and FBXW7 (CDC4, FBW7, AGO, SEL10) mutations in distinct subsets of pancreatic cancer: potential therapeutic targets. , 2003, The American journal of pathology.
[7] R. DePinho,et al. Pancreatic cancer biology and genetics , 2002, Nature Reviews Cancer.
[8] Robert L. Sutherland,et al. Cyclins and Breast Cancer , 1996, Journal of Mammary Gland Biology and Neoplasia.
[9] G. Gaudernack,et al. Mutation detection in KRAS Exon 1 by constant denaturant capillary electrophoresis in 96 parallel capillaries. , 2002, Analytical biochemistry.
[10] P. Malfertheiner,et al. Reduced PTEN expression in the pancreas overexpressing transforming growth factor-beta 1 , 2002, British Journal of Cancer.
[11] F. Couch,et al. BRCA2 and pancreatic cancer , 2002, International journal of gastrointestinal cancer.
[12] Bert Vogelstein,et al. Mutations of mitotic checkpoint genes in human cancers , 1998, Nature.
[13] S. Beghelli,et al. Genetic abnormalities in pancreatic cancer , 2003, Molecular Cancer.
[14] J. Bartek,et al. A series of 14 new monoclonal antibodies to keratins: Characterization and value in diagnostic histopathology , 1991, The Journal of pathology.
[15] Scott E. Kern,et al. DPC4, A Candidate Tumor Suppressor Gene at Human Chromosome 18q21.1 , 1996, Science.
[16] A. Krasinskas,et al. Loss of Heterozygosity Predicts Poor Survival After Resection of Pancreatic Adenocarcinoma , 2008, Journal of Gastrointestinal Surgery.
[17] Todd R. Golub,et al. BRAF mutation predicts sensitivity to MEK inhibition , 2006, Nature.
[18] Jonathan J Ross,et al. Targeted therapy in oncology: the agony and ecstasy of personalized medicine , 2001, Expert review of anticancer therapy.
[19] A. Jemal,et al. Annual report to the nation on the status of cancer, 1975–2001, with a special feature regarding survival , 2004, Cancer.
[20] Zhi Hu,et al. An integrative genomic and proteomic analysis of PIK3CA, PTEN, and AKT mutations in breast cancer. , 2008, Cancer research.
[21] A. Kallioniemi,et al. Pancreatic adenocarcinoma—Genetic portrait from chromosomes to microarrays , 2006, Genes, chromosomes & cancer.
[22] S. Goodman,et al. Tumor-suppressive pathways in pancreatic carcinoma. , 1997, Cancer research.
[23] H. Friess,et al. Application of laser capture microdissection combined with two‐dimensional electrophoresis for the discovery of differentially regulated proteins in pancreatic ductal adenocarcinoma , 2003, Proteomics.
[24] S. Hirohashi,et al. Pancreatic adenocarcinomas frequently show p53 gene mutations. , 1993, The American journal of pathology.
[25] Keith W. Jones,et al. Whole genome DNA copy number changes identified by high density oligonucleotide arrays , 2004, Human Genomics.
[26] J. Howe,et al. A developmental timer regulates degradation of cyclin E1 at the midblastula transition during Xenopus embryogenesis. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[27] T. Yeatman,et al. Analysis of p53, p21WAF1, and TGF-beta1 in human ductal adenocarcinoma of the pancreas: TGF-beta1 protein expression predicts longer survival. , 1998, American journal of clinical pathology.
[28] T. Golub,et al. Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma , 2005, Nature.
[29] C Caldas,et al. Allelotype of pancreatic adenocarcinoma. , 1994, Cancer research.
[30] B. Reid,et al. Single nucleotide polymorphism array analysis of flow-sorted epithelial cells from frozen versus fixed tissues for whole genome analysis of allelic loss in breast cancer. , 2002, The American journal of pathology.
[31] B. Ghadimi,et al. The Genetic Basis of Sporadic Pancreatic Cancer , 2005, Cellular oncology : the official journal of the International Society for Cellular Oncology.